Bionovate Technologies Corp
BIIO · OTC
6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$2 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$2 |
| % Margin | – | – | – | – |
| EPS | -0.002 | -0.005 | -1.34 | -27.63 |
| % Growth | 51% | 99.6% | 95.2% | – |
| EPS Diluted | -0.002 | -0.005 | -1.34 | -27.46 |
| Weighted Avg Shares Out | 45 | 25 | 0 | 0 |
| Weighted Avg Shares Out Dil | 45 | 25 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |